Sort
4,870 grants matching “glp 1”
CNS MEDIATION OF VISCERAL ILLNESS
$201,146University Of Cincinnati · R01 · FY2000 · DK
Problematic avoidant/restrictive eating in adults with functional dyspepsia: the role of endogenous oxytocin and glucagon-like peptide 1
$201,000Helen Burton Murray · Massachusetts General Hospital · R03 · FY2025 · DK
Translational Biomarker Analytical Core (TBAC)
$200,882Blandine B Laferrere · Columbia University Health Sciences · P30 · FY2022 · DK
Translational Biomarker Analytical Core (TBAC)
$200,880Blandine B Laferrere · Columbia University Health Sciences · P30 · FY2020 · DK
Translational Biomarker Analytical Core (TBAC)
$200,880Blandine B Laferrere · Columbia University Health Sciences · P30 · FY2021 · DK
Translational Biomarker Analytical Core (TBAC)
$200,880F. Xavier Pi-Sunyer · Columbia University Health Sciences · P30 · FY2019 · DK
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE
$200,768Massachusetts General Hospital · M01 · FY2001 · RR
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE
$200,768Massachusetts General Hospital · M01 · FY2002 · RR
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE
$200,768Massachusetts General Hospital · M01 · FY2002 · RR
Meal Frequency/Composition Effects on Insulin Resistence in Obese Individuals
$200,717Jill A Kanaley · University Of Missouri-Columbia · R21 · FY2010 · DK
Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetes
$200,620Megan O Bensignor · University Of Minnesota · K23 · FY2023 · DK
Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetes
$200,620Megan O Bensignor · University Of Minnesota · K23 · FY2022 · DK
Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetes
$200,620Megan O Bensignor · University Of Minnesota · K23 · FY2024 · DK
Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetes
$200,620Megan O Bensignor · University Of Minnesota · K23 · FY2025 · DK
A new condom design for encouraging correct and consistent use
$200,601Stacy L Chin · Hydroglyde Coatings, Llc · R43 · FY2016 · HD
Automated Intestinal Electrical Stimulation for Diabetes
$200,330Jiande Chen · Transtimulation Research, Inc. · R43 · FY2013 · DK
Meal Frequency/Composition Effects on Insulin Resistence in Obese Individuals
$200,041Jill A Kanaley · University Of Missouri-Columbia · R21 · FY2009 · DK
Intestinal satiation in Roux-en-Y gastric bypass rats: brain mechanisms and sex d
$200,000Loredana Asarian · University Of Zurich · R01 · FY2011 · DK
Protection and Treatment of the Ocular Surface Barrier
$199,860M. Elizabeth Fini · Proteris Biotech, Inc. · R41 · FY2016 · EY
Translational Biomarker Analytical Core (TBAC)
$199,846F. Xavier Pi-Sunyer · Columbia University Health Sciences · P30 · FY2018 · DK
Targeted Nanoparticles of Bismuth Organo Complexes for Spectral CT Imaging of Cor
$199,770Y Andrew Wang · Ocean Nanotech, Llc · R42 · FY2012 · HL
TAS::75 0849::TAS
$199,757Barbara Olszewska-Pazdrak · Chrysalis Biotherapeutics, Inc. · N43 · FY2011 · CA
Experimental Mouse
$199,698Natalia A Ignatenko · University Of Arizona · P30 · FY2019 · CA
Phase 1 Study of VSV-hIFN-B for the Treatment of Hepatocellular Carcinoma
$199,522Mitesh Borad · Mayo Clinic Arizona · R01 · FY2014 · FD
An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion.
$199,347Glenn W Laub · Tdl Innovations, Llc · SB1 · FY2021 · CA